Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Alx Oncology Holdings (ALXO) Assets Average (2020 - 2023)

Alx Oncology Holdings' Assets Average history spans 4 years, with the latest figure at $233.0 million for Q3 2023.

  • For Q3 2023, Assets Average fell 29.78% year-over-year to $233.0 million; the TTM value through Sep 2023 reached $233.0 million, down 29.78%, while the annual FY2022 figure was $343.3 million, 15.87% down from the prior year.
  • Assets Average for Q3 2023 was $233.0 million at Alx Oncology Holdings, down from $262.0 million in the prior quarter.
  • Across five years, Assets Average topped out at $434.5 million in Q1 2021 and bottomed at $182.8 million in Q3 2020.
  • The 4-year median for Assets Average is $349.3 million (2020), against an average of $334.8 million.
  • The largest annual shift saw Assets Average soared 124.59% in 2021 before it decreased 29.78% in 2023.
  • A 4-year view of Assets Average shows it stood at $349.3 million in 2020, then rose by 11.65% to $390.0 million in 2021, then dropped by 19.97% to $312.1 million in 2022, then dropped by 25.34% to $233.0 million in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Assets Average are $233.0 million (Q3 2023), $262.0 million (Q2 2023), and $292.3 million (Q1 2023).